S&P・Nasdaq 本質的価値 お問い合わせ

Insulet Corporation PODD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$321.45
+59.5%
Analyst Price Target
$357.25
+77.3%

Insulet Corporation (PODD) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Acton, MA, アメリカ. 現CEOは Ashley A. McEvoy.

PODD を有する IPO日 2007-05-15, 5,400 名の正社員, に上場 NASDAQ Global Select, 時価総額 $14.18B.

Insulet Corporation について

Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product is the Omnipod System, a tubeless, self-adhesive disposable insulin pump worn on the body for up to three days, controlled wirelessly by a handheld personal diabetes manager. Insulet distributes its products through independent distributors, pharmacy channels, and direct sales across the United States, Canada, Europe, the Middle East, and Australia. Founded in 2000 and headquartered in Acton, Massachusetts, the company serves a global market of insulin-dependent diabetes patients seeking convenient, modern insulin delivery solutions.

📍 100 Nagog Park, Acton, MA 01720 📞 978 600 7000
会社詳細
セクターヘルスケア
業種Medical - Devices
アメリカ
取引所NASDAQ Global Select
通貨USD
IPO日2007-05-15
CEOAshley A. McEvoy
従業員数5,400
取引情報
現在価格$201.49
時価総額$14.18B
52週レンジ202.44-354.88
ベータ1.47
ETFいいえ
ADRいいえ
CUSIP45784P101
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る